Concepedia

Damien Bosc

DB

Statistics

Publications

16

Citations

497

H-Index

14

Active since

2009

Affiliations

Institut Pasteur de Lille(Current)

Inserm

Université de Lille

Centre National de la Recherche Scientifique

European Genomic Institute for Diabetes

Damien Bosc is an author at Institut Pasteur de Lille specializing in drug discovery, enzymology, and enzyme inhibition.

ORCID

Publications per year

2009–2022

16

Publications

16

Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice

Rebecca Deprez‐Poulain, Nathalie Hennuyer, Damien Bosc et al. · Nature Communications · 2015 · 97 citations · Full text

, , +17

Controlling Plasma Stability of Hydroxamic Acids: A MedChem Toolbox

Paul Hermant, Damien Bosc, Catherine Piveteau et al. · Journal of Medicinal Chemistry · 2017 · 58 citations · Full text

, , +17

A new quinoline-based chemical probe inhibits the autophagy-related cysteine protease ATG4B

Damien Bosc, Lubomir Vezenkov, Svetlana Bortnik et al. · Scientific Reports · 2018 · 51 citations · Full text

, , +17

Development of fluorescent peptide substrates and assays for the key autophagy-initiating cysteine protease enzyme, ATG4B

Lubomir Vezenkov, Nicolette S. Honson, Nag S. Kumar et al. · Bioorganic & Medicinal Chemistry · 2015 · 40 citations

, , +11

Discovery of a New Class of Protein Farnesyltransferase Inhibitors in the Arylthiophene Series

Sébastien Lethu, Maryon Ginisty, Damien Bosc et al. · Journal of Medicinal Chemistry · 2009 · 33 citations

, , +14

1–5 of 16